
Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Private equity firm making control investments in lower middle market companies and partnering with management

Equis Capital Partners is a private equity firm that takes control positions in established companies in the lower middle market. It has invested across a range of industries rather than in a single sector.
Owner-run and management-led companies in the lower middle market, chosen by earnings size rather than by industry. Founders looking to move their business on to its next stage are a core audience.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Equis Capital Partners.
Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Life-science company creator and investor helping scientific founders take therapies from lab to patient

Silicon Valley seed and Series A investor helping early-stage companies find their way

An early-stage venture firm investing in business software companies working on the future of work and education

Early-stage technology investor partnering with founders building software and internet companies in Africa and other under-followed markets

Grant-making programme that supported science-based startups where technology meets biology
Everything here links back to the same verified catalogue. Pick your next stop.